Analyst picks & changes

SangStat Medical Corp.

(SANG), Menlo Park, Calif.

Business: Transplant

UBS Securities analyst Marc Ostro lowered his rating to "hold" from "buy" to reflect changes in the probable launch

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE